Trial Comparing Open vs Thoracoscopic Procedure for Lung Metastases in Osteosarcoma
Phase: Recruiting
Condition(s): Osteosarcoma
NCT Number: NCT05235165 Other Study ID Number(s): AOST2031
What Is the Purpose of This Study?
To determine if open surgical resection is superior to thoracoscopic resection for thoracic event-free survival (tEFS) in patients with resectable oligometastatic pulmonary osteosarcoma.
Who Can Take Part in This Study?
- Patients must be < 50 years at the time of enrollment. Patients must have a diagnosis of osteosarcoma with metastasis to the lungs.
- Patients must have =< 4 nodules per lung.
- Lung nodules must be considered resectable by either open thoracotomy or thoracoscopic surgery. Determination of resectability is made by the institutional surgeon.
What Will Happen During This Study?
- Patients will either undergo open thoracic surgery (thoracotomy) or a thoracoscopy (video-assisted thoracoscopic surgery or VATS).
- Patients undergo CT throughout the trial.
- Patients may also undergo collection of tissue on study and blood throughout the trial.
Principal Investigator
Discover More Research
Explore additional studies relating to sarcoma and solid tumorsYour Might Also Be Interested In
Osteosarcoma
Osteosarcoma is the most common form of bone cancer in young people under age 20. Tumors are lumps or masses and usually affects the long bones near the knee or the shoulder.
Research and Clinical Care: How They Work Together to Treat Children
In this 700 Children's blog post for parents, Nationwide Children's highlights how clinical research and clinical care work together as a key part of our strategic plan to achieve the best outcomes for children. Before delving into these elements work together, the post covers the basics of clinical research.
Stay Updated With Clinical Research. Follow @NCHClinicalResearch on Instagram!
Parents and caregivers can learn more about clinical research on our Instagram channel, @NCHClinicalResearch. You can be part of the clinical research that moves us forward in our journey to best outcomes for all children, everywhere.